183 related articles for article (PubMed ID: 36620234)
1. Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD): Toward improving the adherence of the patients with drug-sensitive tuberculosis in Nashik, Maharashtra.
Saha S; Saxena D; Raval D; Halkarni N; Doshi R; Joshi M; Sridharan M; Sathwara J; Yasobant S; Shah H; Quazi ZS; Rajsekar K; Chowdhury J
Front Public Health; 2022; 10():1021427. PubMed ID: 36620234
[TBL] [Abstract][Full Text] [Related]
2. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
Trials; 2020 May; 21(1):383. PubMed ID: 32370774
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trial.
Tadesse AW; Mohammed Z; Foster N; Quaife M; McQuaid CF; Levy J; van Kalmthout K; van Rest J; Jerene D; Abdurhman T; Yazew H; Umeta DG; Assefa D; Weldemichael GT; Bedru A; Letta T; Fielding KL
BMC Infect Dis; 2021 Nov; 21(1):1149. PubMed ID: 34758737
[TBL] [Abstract][Full Text] [Related]
4. Costs incurred by patients with drug-susceptible pulmonary tuberculosis in semi-urban and rural settings of Western India.
Rupani MP; Cattamanchi A; Shete PB; Vollmer WM; Basu S; Dave JD
Infect Dis Poverty; 2020 Oct; 9(1):144. PubMed ID: 33076969
[TBL] [Abstract][Full Text] [Related]
5. Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients' treatment adherence via electronic monitors and an app versus usual care in Tibet.
Wei X; Hicks JP; Pasang P; Zhang Z; Haldane V; Liu X; Yin T; Wang L; Shi D; Ge S; Walley J; Upshur R; Hu J
Trials; 2019 May; 20(1):273. PubMed ID: 31097023
[TBL] [Abstract][Full Text] [Related]
6. Drones and digital adherence monitoring for community-based tuberculosis control in remote Madagascar: A cost-effectiveness analysis.
Bahrainwala L; Knoblauch AM; Andriamiadanarivo A; Diab MM; McKinney J; Small PM; Kahn JG; Fair E; Rakotosamimanana N; Grandjean Lapierre S
PLoS One; 2020; 15(7):e0235572. PubMed ID: 32634140
[TBL] [Abstract][Full Text] [Related]
7. Tapping private health sector for public health program? Findings of a novel intervention to tackle TB in Mumbai, India.
Shibu V; Daksha S; Rishabh C; Sunil K; Devesh G; Lal S; Jyoti S; Kiran R; Bhavin V; Amit K; Radha T; Sandeep B; Minnie K; Kaur GR; Vaishnavi J; Sudip M; Sameer K; Achutan NS; Sanjeev K; Puneet D
Indian J Tuberc; 2020 Apr; 67(2):189-201. PubMed ID: 32553311
[TBL] [Abstract][Full Text] [Related]
8. Level of adherence to anti-tubercular treatment among drug-sensitive tuberculosis patients on a newly introduced daily dose regimen in South India: A cross-sectional study.
Thamineni R; Peraman R; Chenniah J; Meka G; Munagala AK; Mahalingam VT; Ganesan RM
Trop Med Int Health; 2022 Nov; 27(11):1013-1023. PubMed ID: 36183194
[TBL] [Abstract][Full Text] [Related]
9. ImPROving TB outcomes by modifying LIFE-style behaviours through a brief motivational intervention followed by short text messages (ProLife): study protocol for a randomised controlled trial.
Moriarty AS; Louwagie GM; Mdege ND; Morojele N; Tumbo J; Omole OB; Bachmann MO; Kanaan M; Turner A; Parrott S; Siddiqi K; Ayo-Yusuf OA
Trials; 2019 Jul; 20(1):457. PubMed ID: 31349850
[TBL] [Abstract][Full Text] [Related]
10. Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial.
Browne SH; Umlauf A; Tucker AJ; Low J; Moser K; Gonzalez Garcia J; Peloquin CA; Blaschke T; Vaida F; Benson CA
PLoS Med; 2019 Oct; 16(10):e1002891. PubMed ID: 31584944
[TBL] [Abstract][Full Text] [Related]
11. Adherence to Isoniazid Preventive Therapy among children living with tuberculosis patients in Delhi, India: An exploratory prospective study.
Sharma N; Basu S; Khanna A; Sharma P; Chopra KK; Chandra S
Indian J Tuberc; 2022 Jan; 69(1):100-103. PubMed ID: 35074140
[TBL] [Abstract][Full Text] [Related]
12. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
Thomas BE; Kumar JV; Periyasamy M; Khandewale AS; Hephzibah Mercy J; Raj EM; Kokila S; Walgude AS; Gaurkhede GR; Kumbhar JD; Ovung S; Paul M; Rajkumar BS; Subbaraman R
J Med Internet Res; 2021 Jun; 23(6):e23294. PubMed ID: 34110300
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in Tibet: a multicentre randomised controlled trial.
Wei X; Hicks JP; Zhang Z; Haldane V; Pasang P; Li L; Yin T; Zhang B; Li Y; Pan Q; Liu X; Walley J; Hu J
Lancet; 2024 Mar; 403(10430):913-923. PubMed ID: 38309280
[TBL] [Abstract][Full Text] [Related]
14. Impact of the 99DOTS digital adherence technology on tuberculosis treatment outcomes in North India: a pre-post study.
Chen AZ; Kumar R; Baria RK; Shridhar PK; Subbaraman R; Thies W
BMC Infect Dis; 2023 Jul; 23(1):504. PubMed ID: 37525114
[TBL] [Abstract][Full Text] [Related]
15. Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial.
Sumari-de Boer M; Pima FM; Ngowi KM; Chelangwa GM; Mtesha BA; Minja LM; Semvua HH; Mpagama S; Mmbaga BT; Nieuwkerk PT; Aarnoutse RE
Trials; 2019 Jul; 20(1):426. PubMed ID: 31300028
[TBL] [Abstract][Full Text] [Related]
16. Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India.
Negandhi H; Tiwari R; Sharma A; Nair R; Zodpey S; Reddy Allam R; Oruganti G
Glob Health Action; 2017; 10(1):1290315. PubMed ID: 28485693
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trial.
Maraba N; Orrell C; Chetty-Makkan CM; Velen K; Mukora R; Page-Shipp L; Naidoo P; Mbatha MT; Fielding KL; Charalambous S
Trials; 2021 Jun; 22(1):389. PubMed ID: 34108036
[TBL] [Abstract][Full Text] [Related]
18. The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis.
Arinaminpathy N; Gomez GB; Sachdeva KS; Rao R; Parmar M; Nair SA; Rade K; Kumta S; Hermann D; Hanson C; Chin DP; Dewan P
PLoS One; 2020; 15(3):e0230808. PubMed ID: 32218585
[TBL] [Abstract][Full Text] [Related]
19. Counseling intervention improves treatment adherence among newly diagnosed drug sensitive Tuberculosis patients of Ahmedabad city - A mixed methods approach.
Raval D; Patel P; Sharma R; Shringarpure K
Indian J Tuberc; 2024 Jan; 71(1):19-26. PubMed ID: 38296385
[TBL] [Abstract][Full Text] [Related]
20. Digitizing tuberculosis treatment monitoring in Wuhan city, China, 2020-2021: Impact on medication adherence.
Zhang M; Wang G; Najmi H; Yaqoob A; Li T; Xia Y; Ye J; Hou S; Xiao Y; Zhou L; Li Y
Front Public Health; 2023; 11():1033532. PubMed ID: 36935730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
